New Jersey Business NJ

Kenox Pharmaceuticals expands capabilities to strengthen drug development offerings

Return On Information New Jersey

Jan 29, 2025

Princeton-based Kenox Pharmaceuticals on Tuesday said it is adding small scale non-sterile GMP capabilities to support GLP pre-clinical studies to its comprehensive suite of drug d…

Read the full story at Return On Information New Jersey

Kenox Pharmaceuticals expands capabilities to strengthen drug development offerings

More from New Jersey Business

NJPAC Reveals Memorial Design for Controversial Cathedral House Demolition Site

Statement: Sherrill administration should have delayed New Jersey's new independent contractor regulations

New Report Says N.J. Needs More Affordable Homes for Sale, Not Just Buyer Assistance

100,000 Square Foot Expansion Breaks Ground at Liberty Science Center

Panoramic Manhattan Views and a Private Terrace Define This Avora Residence

New Jersey cannot afford to send mixed signals to business

Team Moza Debuts Casa One, Featuring 196 Rental Residences in Journal Square

Princeton Community Housing to Build Affordable Apartments on Former DPW Site